Research News From October 14, 2007
advertisement
- Differential anti-diabetic efficacy of incretin agonists vs. DPP-4 inhibition in high fat fed mice.
- Beta-cell replacement in immunosuppressed recipients: old and new clinical indications.
- Functional waning of naturally-occurring CD4+ regulatory T cells contributes to the onset of autoimmune diabetes.
- Pluripotency Redux � Advances in Stem-Cell Research. See also Interview with Douglas Melton on the promise and limitations of recent advances in stem-cell research.
- Highly poly(ethylene) glycolylated islets improve long-term islet allograft survival without immunosuppressive medication.
- Inhaled insulin using AERx insulin Diabetes Management System (AERx iDMS).
- Hyperplastic islets observed in “reversed” NOD mice treated without hematopoietic cells.
- Mesenchymal Stem Cells Cooperate with Bone Marrow Cells in Therapy of Diabetes.
- Novel Effectors of Directed and ngn3 Mediated Differentiation of Mouse Embryonic Stem Cells into Endocrine Pancreas Progenitors.
- Encapsulation of porcine islets permits extended culture time and insulin independence in spontaneously diabetic BB rats.
